A population of cells with a CD44+CD29hiCD133/2hi phenotype has also been identified in ERα-negative human breast tumours that was highly tumourigenic, capable of self-renewal and also expressed common stem cell markers [82]. This evidence concerns the gene CD44 and breast neoplasm.